To investigate the impact of the national centralized drug procurement(NCGPO) policy on the clinical use of anticoagulant and antiplatelet drugs in a hospital, and to provide evidence for optimizing pharmaceutical management.
Data on anticoagulant and antiplatelet drug usage were collected for one year before and after the implementation of the first, third, fourth, fifth, seventh, and eighth batches of NCGPO in a hospital, covering 11 selected drugs. The defined daily doses(DDDs), usage proportion of similar drugs, price reduction, expenditure, defined daily cost(DDC), and cost savings were compared before and after NCGPO.
After NCGPO implementation, the unit prices of 28 drugs (including 11 selected drugs) decreased significantly. The DDDs and usage proportion of selected drugs were higher than those of non-NCGPO drugs. The usage of clopidogrel, ticagrelor, dabigatran etexilate, and rivaroxaban(10 mg)increased notably, with a higher proportion in their therapeutic categories. The DDC of all NCGPO drugs decreased, with the largest reduction observed in rivaroxaban tablets(10 mg)(99.20%). Cost savings per batch ranged from 24 200 to 2 814 400 CNY, totaling 8 594 100 CNY.
The NCGPO policy achieved “increased usage and reduced prices,”effectively alleviating patients’ financial burden and enhancing the medical security system.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |